Status:
TERMINATED
CORE: Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial Fibrillation
Lead Sponsor:
Medtronic Cardiac Rhythm and Heart Failure
Collaborating Sponsors:
Medtronic
Conditions:
Heart Failure
Sudden Cardiac Death
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The Medtronic InSync III Marquis Cardiac Resynchronization Therapy Defibrillator (CRT-D)-System (implantable cardioverter-defibrillator with biventricular stimulation for cardiac resynchronization) is...
Eligibility Criteria
Inclusion
- Implant of a Medtronic InSync III Marquis (7279) or later system with Conducted AF-Response
Exclusion
- Medical reasons that are adverse to participation in the study and compliance by the patient
- Patients who are enrolled in another study or plan to be enrolled into another study
- Pregnant patients or patients who are possibly pregnant due to an unreliable form of contraception
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00170313
Start Date
December 1 2003
End Date
January 1 2007
Last Update
July 3 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Aachen
Aachen, Germany, 52066
2
Berufsgenossenschaftliche Kliniken Bergmannsheil
Bochum, Germany, 44789
3
Evangelisches und Johanniter Klinikum Duisburg / Dinslaken / Oberhausen GmbH
Duisburg, Germany, 47137
4
Klinikum der Justus-Liebig-Universität
Giessen, Germany, 35385